BioGend Therapeutics Co., Ltd. (TPEX:6733)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
31.70
+0.05 (0.16%)
Apr 2, 2025, 1:30 PM CST

BioGend Therapeutics Revenue

In the year 2024, BioGend Therapeutics had annual revenue of 167.65M TWD with 52.53% growth. BioGend Therapeutics had revenue of 50.58M in the quarter ending December 31, 2024, with 27.81% growth.

Revenue
167.65M
Revenue Growth
+52.53%
P/S Ratio
23.27
Revenue / Employee
n/a
Employees
n/a
Market Cap
3.94B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024167.65M57.74M52.53%
Dec 31, 2023109.91M78.46M249.51%
Dec 31, 202231.45M22.18M239.26%
Dec 31, 20219.27M7.88M565.40%
Dec 31, 20201.39M-68.00K-4.65%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition